Johnson & Johnson: Porter's Five Forces Industry Analysis
This paper applies three of Porter's Five Forces framework to Johnson & Johnson, one of the world's leading pharmaceutical companies. It examines the intensity of competition in the pharmaceutical industry, the threat posed by potential new entrants enabled by advances in biotechnology, and the bargaining power of raw material suppliers. Drawing on relevant academic and industry sources, the analysis explains how each force shapes Johnson & Johnson's strategic decisions, including investment in research and development, intellectual property protection, and supply chain management. The paper concludes that sustained innovation and proactive supplier relationship management are essential for the company's continued success.
- Introduction: Overview of J&J and three forces examined
- Relevance of the Three Forces to the Pharmaceutical Industry: Why competition, entrants, and suppliers matter
- Competition in the Industry: Intense rivalry among major pharma players
- Potential of New Entrants: Biotech lowers barriers, raising disruption risk
- Power of Suppliers: API suppliers hold leverage over drug manufacturers
- Conclusion: Innovation and supplier management remain critical
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Clearly organizes each of the three forces into its own dedicated section, making the argument easy to follow and each concept easy to assess independently.
- Grounds abstract competitive forces in concrete, real-world examples — such as the COVID-19 vaccine race — to illustrate why competition matters in practice.
- Consistently links each theoretical force back to Johnson & Johnson's specific strategic responses, keeping the analysis applied rather than purely descriptive.
Key academic technique demonstrated
The paper demonstrates applied framework analysis: it takes an established theoretical model (Porter's Five Forces) and systematically maps each force onto a specific company and industry. This technique shows the ability to move from abstract theory to concrete organizational implications, which is a core skill in business and strategy coursework.
Structure breakdown
The paper opens with an introduction identifying the company and the three forces under examination. A combined section then establishes why all three forces are relevant to the pharmaceutical industry broadly. Three individual sections follow — one per force — each explaining the general dynamic and then specifying how Johnson & Johnson must respond. A brief conclusion synthesizes the strategic takeaways. The Works Cited section lists six sources in MLA format.
Introduction
Johnson & Johnson is a multinational pharmaceutical company that operates in a highly competitive industry. Three of Porter's Five Forces — competition in the industry, the potential of new entrants, and the power of suppliers — are significant factors that affect the company's business operations and success. This paper provides an analysis of these three forces and their impact on Johnson & Johnson.
Works Cited
Gassmann, Oliver, et al. "The Industry Challenge: Who Would Want to Be in This Business?" Leading Pharmaceutical Innovation: How to Win the Life Science Race (2018): 17–39.
Leeuw, Bas J. de, Peter de Wolf, and Frans A. J. den van Bosch. "The Changing Role of Technology Suppliers in the Pharmaceutical Industry: The Case of Drug Delivery Companies." International Journal of Technology Management 25.3–4 (2003): 350–362.
Olasiuk, Hanna. "Competitive Forces on the Ukrainian Pharmaceutical Market: Evaluation Aspects." Journal of Applied Management and Investments 6.3 (2017): 186–196.
Porter, Michael E. "The Five Competitive Forces That Shape Strategy." Harvard Business Review 86.1 (2008): 78.
Prayogi, Reynaldy, and Harimukti Wandebori. "Proposed Strategy for Pharmaceutical Industry (Case Study: PT Bio Farma Persero)." European Journal of Business and Management Research 5.5 (2020).
Sultana, Jesmin. "Future Prospects and Barriers of Pharmaceutical Industries in Bangladesh." Bangladesh Pharmaceutical Journal 19.1 (2016): 53–57.
Create your account
Always verify citation format against your institution’s current style guide requirements.